Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-25-001017
Filing Date
2025-03-25
Accepted
2025-03-25 16:06:11
Documents
6
Effectiveness Date
2025-03-25

Document Format Files

Seq Description Document Type Size
1 S-8 zk2532919.htm S-8 82434
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 5279
3 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 3854
4 FILING FEES TABLE exhibit_107.htm EX-FILING FEES 31654
5 image0.jpg GRAPHIC 42244
6 image1.jpg GRAPHIC 38245
  Complete submission text file 0001178913-25-001017.txt   235102
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: S-8 | Act: 33 | File No.: 333-286082 | Film No.: 25768301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)